Skip to main content
Premium Trial:

Request an Annual Quote

Certara Teams up with the Hamner Institutes for Health Sciences to Explore Liver Toxicity

Premium

Certara said this week that it is collaborating with the Hamner Institutes for Health Sciences to explore drug-induced liver toxicity.

Under the terms of the agreement signed by both parties, the partners will integrate the Hamner's drug-induced liver injury, DILI, modeling software into Certara's Simcyp simulator and test the integrated product's simulation capabilities with respect to drug exposure and resultant liver toxicity.

Brett Howell, lead scientist and manager of the DILI-simulation initiative at the Hamner, said that the collaborators aim to develop "a computer model that helps sponsors and regulators predict which drugs will produce DILI symptoms, and which subsets of the population are most likely to be affected."

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more